跳至主要内容
临床试验/ISRCTN12390945
ISRCTN12390945进行中(未招募)Unknown

A multi-centre, open-label, two-arm, parallel group, individually randomised trial, with an internal pilot and economic evaluation, to test the superiority of Snacktivity compared with usual care

Birmingham Community Healthcare NHS Trust0 个研究点目标入组 724 人开始时间: 2024年3月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
724

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Completes <150 minutes per week of moderate to vigorous physical activity (MVPA) as assessed by the Physical Activity Vital Sign (PAVS) Questionnaire
  • 2. Able to provide informed written consent
  • 3. Aged >=18 years (all routes of recruitment)
  • 4. Own a mobile phone capable of hosting apps (Apple iOS 13.0+ and Android 4.3+)
  • 5. Agreement for their healthcare professional (HCP) to be notified of their involvement in the trial

排除标准

  • 1. Unable to understand English sufficiently to complete the trial assessments
  • 2. Women known to be pregnant or breastfeeding
  • 3. Inpatient, bedbound or unable to complete physical activity

研究者

发起方
Birmingham Community Healthcare NHS Trust

相似试验

已完成
不适用
A Multicenter, Open-label, Two-arm Parallel-group, Non-inferiority Investigator-Initiated Trial to compare efficacy and safety of LObeglitazone or linagliptin add-on triple therapy in Type 2 Diabetes Mellitus patients under stable treatment with MEtformin and emPAglifloziEndocrine, nutritional and metabolic diseases
KCT0004509Chonnam National University Hospital Hwasun Hospital136
进行中(未招募)
1 期
Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients withT2DMType 2 diabetes mellitusMedDRA version: 17.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2014-001253-16-DESanofi-aventis recherche & développement
招募中
1 期
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageate-onset sepsis (LOS) in term and pre-term neonates andinfants up to 3 months of age.MedDRA version: 20.1Level: LLTClassification code 10053598Term: Late onset neonatal sepsisSystem Organ Class: 100000004862
EUCTR2022-001837-35-LTBasilea Pharmaceutica International Ltd, Allschwil15
进行中(未招募)
1 期
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageate-onset sepsis (LOS) in term and pre-term neonates andinfants up to 3 months of age.MedDRA version: 20.1Level: LLTClassification code 10053598Term: Late onset neonatal sepsisSystem Organ Class: 100000004862
EUCTR2022-001837-35-PLBasilea Pharmaceutica International Ltd, Allschwil15
进行中(未招募)
1 期
ate-onset sepsis in term and pre-term neonates and infants up to 3 months of ageate-onset sepsis (LOS) in term and pre-term neonates andinfants up to 3 months of age.MedDRA version: 20.1Level: LLTClassification code 10053598Term: Late onset neonatal sepsisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2022-001837-35-SKBasilea Pharmaceutica International Ltd, Allschwil8
Snacktivity to promote physical activity WP4 | 临床试验